October 23, 2020Separation Agreement and General Release • February 16th, 2021 • Immunovant, Inc. • Biological products, (no disgnostic substances) • New York
Your employment with IMVT Corporation (“Immunovant”) will be terminated effective November 6, 2020 (the “Separation Date”). This Separation Agreement and General Release (this “Agreement”) sets forth the terms and conditions under which IMVT Corporation is offering you additional pay and benefits in exchange for you making and honoring certain commitments, including agreeing not to pursue legal action against the Company as described in Sections 7 and 8.
